Clinical Trial Update: Control of Epistaxis With Surgiflo [NA]

View source ↗

Summary

A clinical trial evaluating Surgiflo for control of epistaxis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis

Drugs mentioned

• Surgiflo (gelatin-thrombin hemostatic matrix)

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Epistaxis | NA | Status: TERMINATED